Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection(25R) versus Humalog Mix25 in newly diagnosed type 2 diabetes
ChiCTR1800015829Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro protamine + insulin lispro and insulin lispro mix25 in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Mean blood glucose. Started Apr 2018; status: recruiting.
02
Drugs
insulin lispro protamine + insulin lisproinsulin lispro mix25
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800015829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015829.